![Virtual Booth](https://www.pharmacompass.com/image/vb/vb-orange-btn.png)
![EuroAPI Header](https://www.pharmacompass.com/image/flap/euroapi-w34-desktop-headergif-72716.gif)
![EuroAPI Header](https://www.pharmacompass.com/image/flap/euroapi-w34-mob-headergif-95876.gif)
20
Siegfried Evionnaz Sa Evionnaz Ch, based in Switzerland, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.
One of their significant offerings is Oxybuprocaine hydrochloride, supported by a 'Valid' Certificate of Suitability (CEP) with the number R0-CEP 2022-104 - Rev 00
This Chemical Type CEP, issued on August 31, 2023, remains in force until January 01, 1970, ensuring its reliability within the pharmaceutical industry.
Substance Number 1251 associated with this CEP further emphasizes